Prevention of ovarian hyperstimulation syndrome: novel strategies.
Grudzinskas
J G
JG
Department of Obstetrics & Gynaecology, St Bartholomew's and The Royal London School of Medicine & Dentistry, Royal London Hospital Hospital, Whitechapel, UK.
Egbase
P E
PE
D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006062:Gonadotropins / Q000008:administration & dosage; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000209:etiology / Q000517:prevention & control*; D010062:Ovulation Induction / Q000009:adverse effects / Q000379:methods; D013997:Time Factors
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D007987:Gonadotropin-Releasing Hormone